Latest Insider Transactions at Bio Techne Corp (TECH)
This section provides a real-time view of insider transactions for Bio Techne Corp (TECH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BIO-TECHNE Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BIO-TECHNE Corp's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 14
2024
|
John L Higgins Director |
SELL
Open market or private sale
|
Direct |
4,000
-9.85%
|
$332,000
$83.84 P/Share
|
May 14
2024
|
John L Higgins Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+8.97%
|
$88,000
$22.95 P/Share
|
May 01
2024
|
Judith V Klimovsky Director |
BUY
Grant, award, or other acquisition
|
Direct |
680
+50.0%
|
-
|
Apr 03
2024
|
Shane Bohnen SVP - General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
747
-31.2%
|
$50,049
$67.87 P/Share
|
Apr 03
2024
|
Shane Bohnen SVP - General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,259
+48.55%
|
-
|
Mar 07
2024
|
Roeland Nusse Director |
SELL
Open market or private sale
|
Direct |
10,400
-19.44%
|
$790,400
$76.98 P/Share
|
Feb 01
2024
|
William Geist PRESIDENT, PROTEIN SCIENCES |
SELL
Payment of exercise price or tax liability
|
Direct |
1,111
-12.53%
|
$75,548
$68.54 P/Share
|
Dec 19
2023
|
James Hippel CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
32,966
-31.44%
|
$2,538,382
$77.42 P/Share
|
Dec 19
2023
|
James Hippel CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
47,289
+31.08%
|
$1,465,959
$31.26 P/Share
|
Nov 01
2023
|
Kim Kelderman Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,196
+28.61%
|
-
|
Oct 26
2023
|
Alpna Seth Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,625
+11.66%
|
-
|
Oct 26
2023
|
Rupert Vessey Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,625
+17.09%
|
-
|
Oct 26
2023
|
Julie L Bushman Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,625
+22.27%
|
-
|
Oct 26
2023
|
John L Higgins Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,625
+4.25%
|
-
|
Oct 26
2023
|
Randolph C Steer Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,625
+6.29%
|
-
|
Oct 26
2023
|
Roeland Nusse Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,625
+2.95%
|
-
|
Oct 26
2023
|
Joseph D Keegan Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,625
+11.66%
|
-
|
Oct 26
2023
|
Robert V Baumgartner Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,625
+3.61%
|
-
|
Aug 30
2023
|
Roeland Nusse Director |
SELL
Open market or private sale
|
Direct |
8,939
-14.7%
|
$715,120
$80.32 P/Share
|
Aug 30
2023
|
Roeland Nusse Director |
BUY
Exercise of conversion of derivative security
|
Direct |
32,000
+23.57%
|
$704,000
$22.4 P/Share
|
Aug 24
2023
|
Kim Kelderman Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,100
+9.0%
|
$98,700
$47.6 P/Share
|
Aug 15
2023
|
Charles R. Kummeth Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,675
-0.67%
|
$728,700
$84.61 P/Share
|
Aug 15
2023
|
Charles R. Kummeth Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,632
+1.35%
|
-
|
Aug 09
2023
|
Charles R. Kummeth Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
9,008
-0.7%
|
-
|
Aug 05
2023
|
James Hippel CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,335
-9.91%
|
$519,470
$82.17 P/Share
|
Aug 05
2023
|
James Hippel CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,876
+16.77%
|
-
|
Aug 05
2023
|
Charles R. Kummeth Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
31,962
-2.44%
|
$2,620,884
$82.17 P/Share
|
Aug 05
2023
|
Charles R. Kummeth Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
51,516
+3.78%
|
-
|
Aug 05
2023
|
Kim Kelderman Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,139
-17.79%
|
$339,398
$82.17 P/Share
|
Aug 05
2023
|
Kim Kelderman Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,060
+25.73%
|
-
|
Jul 21
2023
|
Charles R. Kummeth Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
80,000
-5.98%
|
$7,040,000
$88.36 P/Share
|
Jun 30
2023
|
Charles R. Kummeth Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
390,727
-22.59%
|
$31,648,887
$81.63 P/Share
|
Jun 30
2023
|
Charles R. Kummeth Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
616,676
+26.28%
|
$16,033,576
$26.65 P/Share
|
Jun 07
2023
|
Charles R. Kummeth Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
322
-0.03%
|
$26,726
$83.0 P/Share
|
Apr 28
2023
|
John L Higgins Director |
SELL
Payment of exercise price or tax liability
|
Direct |
4,377
-11.12%
|
$345,783
$79.88 P/Share
|
Apr 28
2023
|
John L Higgins Director |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+28.9%
|
$336,000
$21.85 P/Share
|
Apr 19
2023
|
Roeland Nusse Director |
SELL
Bona fide gift
|
Direct |
377
-1.29%
|
-
|
Jan 04
2023
|
Charles R. Kummeth Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
255,837
-18.69%
|
$21,490,308
$84.39 P/Share
|
Jan 04
2023
|
Charles R. Kummeth Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
407,364
+22.93%
|
$10,591,464
$26.65 P/Share
|
Dec 08
2022
|
Brenda S. Furlow SVP - GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
7,450
-22.21%
|
$610,900
$82.12 P/Share
|
Dec 08
2022
|
Brenda S. Furlow SVP - GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
7,450
+18.17%
|
$230,950
$31.26 P/Share
|
Dec 07
2022
|
Brenda S. Furlow SVP - GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
800
-2.97%
|
$65,600
$82.01 P/Share
|
Dec 07
2022
|
Brenda S. Furlow SVP - GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
800
+2.89%
|
$24,800
$31.26 P/Share
|
Oct 27
2022
|
Randolph C Steer Director |
BUY
Grant, award, or other acquisition
|
Direct |
338
+5.65%
|
-
|
Oct 27
2022
|
Alpna Seth Director |
BUY
Grant, award, or other acquisition
|
Direct |
338
+11.23%
|
-
|
Oct 27
2022
|
Julie L Bushman Director |
BUY
Grant, award, or other acquisition
|
Direct |
338
+25.04%
|
-
|
Oct 27
2022
|
Joseph D Keegan Director |
BUY
Grant, award, or other acquisition
|
Direct |
338
+11.23%
|
-
|
Oct 27
2022
|
Roeland Nusse Director |
BUY
Grant, award, or other acquisition
|
Direct |
338
+4.43%
|
-
|
Oct 27
2022
|
Rupert Vessey Director |
BUY
Grant, award, or other acquisition
|
Direct |
338
+17.76%
|
-
|
Oct 27
2022
|
Robert V Baumgartner Director |
BUY
Grant, award, or other acquisition
|
Direct |
338
+3.13%
|
-
|